Author(s): Antaki F, French MM, Moonka DK, Gordon SC
Abstract Share this page
Abstract Bioelectrical impedance analysis (BIA) is a non-invasive technique that measures electrical resistance (R) and reactance (Xc), which are then used to calculate phase angle (PA). The aim of this pilot study was to assess whether BIA can differentiate between minimal and advanced hepatic fibrosis in patients with chronic hepatitis C (HCV) infection. Twenty patients with HCV participated in this study, and were divided into minimal (Metavir 1) and advanced (Metavir 3 or 4) fibrosis groups. We obtained BIA measurements (R and Xc) in several axes and calculated PA from each pair of measurements. We found no statistically significant differences between the two groups with respect to PA, R, or Xc for the whole body, the trunk or the right upper quadrant measurements in any axis. Mean whole body PA was 7.0 and 7.1 (P = 0.9) in the minimal and advanced fibrosis groups, respectively. Bioelectrical impedance analysis did not demonstrate the ability to distinguish between minimal and advanced degrees of hepatic fibrosis in patients with chronic HCV infection.
This article was published in Dig Dis Sci
and referenced in Journal of Antivirals & Antiretrovirals